PrEP Clinical Trials 2022

Browse 30 Prep Medical Studies Across 117 Cities

4 Phase 3 Trial · 215 Prep Clinics

Reviewed by Michael Gill, B. Sc.
Photo of Boston 1
Phase-Based Progress Estimates
1
Effectiveness
1
Safety

HIV Self-testingfor Pre-Exposure Prophylaxis

Boston, MA
18+
All Sexes
The goal of this study is to determine the feasibility and acceptability of an intervention (Rapid PrEP Access) providing people who inject drugs (PWID) immediate access to PrEP prescriptions through same-day human immunodeficiency virus (HIV) self-testing, HIV viral load dried blood spot (DBS) testing and on-site prescriptions at a Mobile Prevention Services Van. Aim 1: To implement 'Rapid PrEP Access' at a Mobile Prevention Services Van to increase uptake of PrEP among PWID. Aim 2: To determine the feasibility and acceptability of 'Rapid PrEP Access' at a Mobile Prevention Services Van. At the current time the Victory program in collaboration with Boston Medical Center (BMC) and the Department of Public Health (DPH) offers HIV testing to its clients; however, this HIV testing is performed through laboratory-based testing which requires a blood draw. PrEP is not currently offered through the Victory program. As part of this study, HIV testing in the form of HIV self-testing (as opposed to laboratory-based testing offered through BMC/DPH) will be offered as well as HIV PrEP for individuals who test negative on HIV self-test and are interested in PrEP. The investigators will also perform HIV viral load dried blood spot (DBS) testing to confirm the absence of HIV. Results for confirmatory DBS testing will be available after enrollment. HIV PrEP and HIV self-testing are FDA approved and CDC recommended, but their uptake in the community among individuals who are at-risk has been low. Therefore, the goal of this pilot study is to increase uptake by bringing these measures to the communities that are most in need. The study will offer immediate access to PrEP through an intervention that utilizes point-of-care HIV self-testing, HIV DBS testing for viral load quantification and confirmatory testing, followed by evaluation for PrEP and on-site PrEP initiation by a nurse practitioner for eligible patients. Participants will also have additional PrEP-related testing that are part of regular clinical care performed at Victory Program. These tests include standard sexually transmitted infections (STI) testing (ie. syphilis, chlamydia, gonorrhea, hepatitis B & C) and renal function testing. A baseline assessment followed by evaluations at 3 and 6 months will be obtained on study participants. After completing baseline assessments at the mobile van, study staff will encourage individuals to follow-up at BMC for longitudinal clinical care.
Waitlist Available
Has No Placebo
25 Prep Clinical Trials Near Me
Boston, MA
New Orleans, LA
New Orleans, LA
Newark, NJ
More Trial Locations
An interactive map to display trial locations for Victory Program, CrescentCare PrEP Clinic, LSU-CrescentCare Sexual Health Center, Rutgers School of Nursing, and 95 more locations.
Most Popular References for Prep Clinical Trials
Frequency
Citation
Top Hospitals for Prep Clinical Trials
Location
Active Prep Clinical Trials
All Time Trials for Prep
First Recorded Prep Trial
Trials
San Francisco AIDS Foundation, San Francisco, California
2
2
2021
Victory Program, Boston, Massachusetts
1
1
2022
CrescentCare PrEP Clinic, New Orleans, Louisiana
1
1
2022
Top Treatments for Prep Clinical Trials
Treatment Name
Active Prep Clinical Trials
All Time Trials for Prep
First Recorded Prep Trial
Trials
PrEP Romania
1
1
2021
Peer-driven intervention
1
1
2022
Phase 3 Prep Clinical Trials
Pediatric Prep Clinical Trials
Senior Friendly Prep Clinical Trials

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 11th, 2021

Last Reviewed: August 6th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.